Annual Reports

 
Quarterly Reports

 
8-K

 
Other

  • EFFECT (Aug 29, 2014)
  • S-3 (Aug 22, 2014)
  • Form 4 (Aug 15, 2014)
  • DEF 14A (Jun 27, 2014)
  • Form 4 (Jun 10, 2014)
  • Form 4 (May 29, 2014)
Summer Infant DEFA14A 2007

Documents found in this filing:

  1. Defa14A
  2. Ex-99.1
  3. Ex-99.1
Form 8-K Amendment

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


FORM 8-K/A

(Amendment No. 7)

 


CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 1, 2006

 


KBL HEALTHCARE ACQUISITION

CORP. II

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware   000-51228   20-1994619

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

757 Third Avenue, 21st Floor, New York, New York   10017
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (212) 319-5555

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



KBL HEALTHCARE ACQUISITION CORP. II (“KBL”) IS HOLDING PRESENTATIONS FOR CERTAIN OF ITS STOCKHOLDERS, AS WELL AS OTHER PERSONS WHO MIGHT BE INTERESTED IN PURCHASING KBL’S SECURITIES, REGARDING ITS ACQUISITION OF SUMMER INFANT, INC. AND AFFILIATED COMPANIES (“SUMMER”), AS DESCRIBED IN THE SEPTEMBER 5, 2006 8-K FILING AS AMENDED BY 8-K AMENDMENT NO. 1 FILED SEPTEMBER 19, 2006, 8-K AMENDMENT NO. 2 FILED OCTOBER 23, 2006, 8-K AMENDMENT NO. 3 FILED OCTOBER 26, 2006, 8-K AMENDMENT NO. 4 FILED NOVEMBER 16, 2006, AMENDMENT NO. 5 FILED JANUARY 16, 2007, AMENDMENT NO. 6 FILED JANUARY 25, 2007 AND AMENDMENT NO. 7 FILED HEREBY. SUCH CURRENT REPORT AND AMENDMENTS, INCLUDING SOME OR ALL OF THE EXHIBITS THERETO AND HERETO, ARE BEING DISTRIBUTED TO ATTENDEES OF THESE PRESENTATIONS.

EARLYBIRDCAPITAL, INC. (‘EBC”), THE MANAGING UNDERWRITER OF KBL’S INITIAL PUBLIC OFFERING (“IPO”) CONSUMMATED IN APRIL 2005, IS ASSISTING KBL IN THESE EFFORTS WITHOUT CHARGE, OTHER THAN THE REIMBURSEMENT OF ITS OUT-OF-POCKET EXPENSES, ALTHOUGH EBC WILL BE PAID A CASH FEE AT THE CLOSING OF THE ACQUISITION EQUAL TO ONE PERCENT (1%) OF THE CONSIDERATION PAID IN THE ACQUISITION. KBL AND ITS DIRECTORS AND EXECUTIVE OFFICERS AND EBC MAY BE DEEMED TO BE PARTICIPANTS IN THE SOLICITATION OF PROXIES FOR THE SPECIAL MEETING OF KBL STOCKHOLDERS TO BE HELD TO APPROVE THE ACQUISITION.

STOCKHOLDERS OF KBL AND OTHER INTERESTED PERSONS ARE ADVISED TO READ KBL’S PRELIMINARY PROXY STATEMENT FILED WITH THE SEC ON OCTOBER 23, 2006 AS AMENDED ON DECEMBER 12, 2006 AND JANUARY 10, 2002 AND, WHEN AVAILABLE, DEFINITIVE PROXY STATEMENT IN CONNECTION WITH KBL’S SOLICITATION OF PROXIES FOR THE SPECIAL MEETING BECAUSE THESE PROXY STATEMENTS WILL CONTAIN IMPORTANT INFORMATION. SUCH PERSONS CAN ALSO READ KBL’S FINAL PROSPECTUS, DATED APRIL 21, 2005, FOR A DESCRIPTION OF THE SECURITY HOLDERS OF KBL’S OFFICERS AND DIRECTORS AND OF EBC AND THEIR RESPECTIVE INTERESTS IN THE SUCCESSFUL CONSUMMATION OF THIS BUSINESS COMBINATION. THE DEFINITIVE PROXY STATEMENT WILL BE MAILED TO STOCKHOLDERS AS OF A RECORD DATE TO BE ESTABLISHED FOR VOTING ON THE ACQUISITION. STOCKHOLDERS WILL ALSO BE ABLE TO OBTAIN A COPY OF THE DEFINITIVE PROXY STATEMENT, WITHOUT CHARGE, BY DIRECTING A REQUEST TO: KBL HEALTHCARE ACQUISITION CORP. II, 757 THIRD AVENUE, NEW YORK, NEW YORK 10017. THE PRELIMINARY PROXY STATEMENT AND DEFINITIVE PROXY STATEMENT, ONCE AVAILABLE, AND THE FINAL PROSPECTUS CAN ALSO BE OBTAINED, WITHOUT CHARGE, AT THE SEC’S INTERNET SITE (HTTP://WWW.SEC.GOV).

SUMMER’S FINANCIAL INFORMATION CONTAINED HEREIN IS UNAUDITED AND PREPARED BY SUMMER AS A PRIVATE COMPANY, IN ACCORDANCE WITH U.S. GENERALLY ACCEPTED ACCOUNTING PRINCIPLES, AND MAY NOT CONFORM TO SEC REGULATION S-X. ACCORDINGLY, SUCH HISTORICAL INFORMATION MAY BE ADJUSTED AND PRESENTED DIFFERENTLY IN KBL’S PROXY STATEMENT TO SOLICIT STOCKHOLDER APPROVAL OF THE ACQUISITION.

 

Item 8.01 Other Events.

On January 29, 2007, KBL Healthcare Acquisition Corp. II (“KBL”) announced that that its special meeting of stockholders will be held on March 6, 2007 at 10:00 a.m. eastern time and that stockholders of record as of February 6, 2007 will be invited to attend the special meeting to vote on five proposals, including (i) the approval of the Agreement and Plans of Reorganization, dated September 1, 2006, among KBL, SII Acquisition, Inc., Summer Infant, Inc. and its affiliated companies (“Summer”) and the stockholders of Summer, pursuant to which the Summer companies will be acquired by KBL, (ii) the approval of amendment to the certificate of incorporation of KBL to change the name of KBL from “KBL Healthcare Acquisition Corp. II” to “Summer Infant, Inc.,” (iii) the approval of an amendment to the certificate of incorporation of KBL to increase its authorized capitalization, (iv) the approval of an amendment to the certificate of incorporation of KBL to remove those provisions that will no longer be operative upon consummation of the merger, and (v) the approval of the Performance Equity Plan. A copy of the press release for such announcement is attached to this Report as Exhibit 99.1.

 

2


Item 9.01. Financial Statements, Pro Forma Financial Information and Exhibits.

(c) Exhibits:

 

Exhibit   

Description

99.1    Press Release

 

3


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 29, 2007     KBL HEALTHCARE ACQUISITION CORP. II
      By:   /s/ Michael Kaswan
      Name:   Michael Kaswan
      Title:   Chief Operating Officer

 

4

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki